POAI logo

Predictive Oncology (POAI) Return On Equity

Annual ROE

-93.11%
-10.13%-12.21%

31 December 2023

POAI ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly ROE

-232.54%
-68.44%-41.71%

30 September 2024

POAI Quarterly ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

POAI ROE Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.2%-143.0%
3 y3 years+75.0%-201.1%
5 y5 years+87.3%-131.3%

POAI ROE High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-12.2%+75.0%-419.6%at low
5 y5 years-12.2%+87.3%-419.6%+13.5%
alltimeall time-116.3%+87.3%-121.4%+94.7%

Predictive Oncology ROE History

DateAnnualQuarterly
Sept 2024
-
-232.54%(+41.7%)
June 2024
-
-164.10%(+27.1%)
Mar 2024
-
-129.12%(+38.4%)
Dec 2023
-93.11%(+12.2%)
-93.29%(-2.5%)
Sept 2023
-
-95.69%(+17.0%)
June 2023
-
-81.76%(-10.8%)
Mar 2023
-
-91.69%(+15.7%)
Dec 2022
-82.98%(-9.4%)
-79.27%(+16.7%)
Sept 2022
-
-67.90%(+6.7%)
June 2022
-
-63.62%(+42.2%)
Mar 2022
-
-44.75%(-18.4%)
Dec 2021
-91.62%(-75.4%)
-54.81%(-29.0%)
Sept 2021
-
-77.23%(-26.6%)
June 2021
-
-105.21%(-39.6%)
Mar 2021
-
-174.16%(-35.2%)
Dec 2020
-373.14%(+8.6%)
-268.75%(+27.3%)
Sept 2020
-
-211.15%(+25.5%)
June 2020
-
-168.25%(+5.5%)
Mar 2020
-
-159.50%(-10.6%)
Dec 2019
-343.66%(-53.2%)
-178.35%(+77.4%)
Sept 2019
-
-100.56%(-25.5%)
June 2019
-
-135.07%(-72.7%)
Mar 2019
-
-495.39%(+41.0%)
Dec 2018
-734.79%(+121.3%)
-351.46%(+50.1%)
Sept 2018
-
-234.22%(+25.5%)
June 2018
-
-186.59%(+1.0%)
Mar 2018
-
-184.82%(-19.5%)
Dec 2017
-332.06%(+28.1%)
-229.48%(-14.9%)
Sept 2017
-
-269.75%(-15.4%)
June 2017
-
-318.67%(-7.8%)
Mar 2017
-
-345.59%(-11.4%)
Dec 2016
-259.15%
-390.10%(+28.4%)
DateAnnualQuarterly
Sept 2016
-
-303.89%(-46.8%)
June 2016
-
-571.68%(-87.0%)
Mar 2016
-
-4380.88%(-502.8%)
Dec 2015
-116.48%(-194.0%)
1087.51%(+532.9%)
Sept 2015
-
171.82%(+84.8%)
June 2015
-
93.00%(-22.6%)
Mar 2015
-
120.15%(-37.4%)
Dec 2014
123.88%(-57.6%)
192.07%(-13.5%)
Sept 2014
-
221.98%(-45.5%)
June 2014
-
407.51%(+9.3%)
Mar 2014
-
372.69%(+6.6%)
Dec 2013
292.26%(+30.1%)
349.56%(+5.7%)
Sept 2013
-
330.72%(+25.0%)
June 2013
-
264.57%(-20.1%)
Mar 2013
-
331.06%(+19.9%)
Dec 2012
224.70%(+35.4%)
276.09%(-19.2%)
Sept 2012
-
341.67%(+37.3%)
June 2012
-
248.91%(+39.3%)
Mar 2012
-
178.74%(-1.9%)
Dec 2011
165.98%(+168.7%)
182.17%(+122.0%)
Sept 2011
-
82.06%(+28.8%)
June 2011
-
63.72%(+25.3%)
Mar 2011
-
50.85%(-17.9%)
Dec 2010
61.78%(-50.0%)
61.94%(+3.3%)
Sept 2010
-
59.99%(-29.8%)
June 2010
-
85.45%(-23.2%)
Mar 2010
-
111.32%(-11.1%)
Dec 2009
123.49%(-78.3%)
125.15%(-51.2%)
Sept 2009
-
256.62%(-73.5%)
June 2009
-
968.75%(+32.6%)
Mar 2009
-
730.54%(+80.1%)
Dec 2008
569.68%
405.56%

FAQ

  • What is Predictive Oncology annual return on equity?
  • What is the all time high annual ROE for Predictive Oncology?
  • What is Predictive Oncology annual ROE year-on-year change?
  • What is Predictive Oncology quarterly return on equity?
  • What is the all time high quarterly ROE for Predictive Oncology?
  • What is Predictive Oncology quarterly ROE year-on-year change?

What is Predictive Oncology annual return on equity?

The current annual ROE of POAI is -93.11%

What is the all time high annual ROE for Predictive Oncology?

Predictive Oncology all-time high annual return on equity is 569.68%

What is Predictive Oncology annual ROE year-on-year change?

Over the past year, POAI annual return on equity has changed by -10.13% (-12.21%)

What is Predictive Oncology quarterly return on equity?

The current quarterly ROE of POAI is -232.54%

What is the all time high quarterly ROE for Predictive Oncology?

Predictive Oncology all-time high quarterly return on equity is 1087.51%

What is Predictive Oncology quarterly ROE year-on-year change?

Over the past year, POAI quarterly return on equity has changed by -136.85% (-143.01%)